Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient

Urs Christen1, Dirk Benke, Tom Wolfe

  • 1Department of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA.

Insights

Viral infections can prevent type 1 diabetes (T1D) by reprogramming immune responses. Lymphocytic choriomeningitis virus (LCMV) infection in mice reduced T1D development through chemokine IP-10 and cytokine signaling.

Area of Science:

  • Immunology
  • Virology
  • Endocrinology

Background:

  • Viruses exhibit a dual role in autoimmune diseases, capable of both triggering and preventing them.
  • Establishing a direct causal link between viral infections and type 1 diabetes (T1D) has been challenging due to this complexity.

Purpose of the Study:

  • To elucidate the mechanisms by which viral infections influence autoimmune disease development.
  • To investigate the potential of viral infections as a therapeutic strategy for T1D.

Main Methods:

  • Prediabetic mice (NOD and RIP-LCMV models) were infected with lymphocytic choriomeningitis virus (LCMV).
  • Immune cell trafficking, apoptosis, chemokine expression (IP-10/CXCL10), and cytokine blockade (TNF-alpha, IFN-gamma) were analyzed.

Main Results:

  • LCMV infection completely prevented diabetes development in both mouse models.
  • Infection led to T lymphocyte recruitment to the pancreatic lymph node with increased apoptosis, associated with IP-10 expression.
  • Blocking TNF-alpha or IFN-gamma abolished the protective effect, indicating their crucial role.

Conclusions:

  • Virally induced proinflammatory cytokines and chemokines can beneficially modulate preclinical autoimmune processes.
  • The precise location, timing, and levels of these mediators are critical for therapeutic efficacy in preventing T1D.